We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00800462
First Posted: December 2, 2008
Last Update Posted: April 8, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Ontario Neurotrauma Foundation
Information provided by (Responsible Party):
Magdy Hassouna, Toronto Rehabilitation Institute
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)